Sahajanand Medical Technologies Ltd.

Sahajanand Medical Technologies Ltd. At SMT, we are revolutionizing healthcare through innovation and clinical excellence.

With a presence in 80+ countries and a diverse global workforce, SMT is driving innovation to meet the needs of healthcare professionals. We are a leading developer and manufacturer of minimally invasive coronary stent systems, with one of the broadest product portfolios in the industry. We at SMT believe in continuous innovation and up-gradation of our portfolio in order to cater to your healthcare needs. Our commitment is to advance patient care by introducing state of the art medical devices which will enable us to save precious lives.

On 30 January 2026, ISIC hosted a scientific session at Hotel Padma, Semarang, focused on the evolving role of BP-SES — ...
25/02/2026

On 30 January 2026, ISIC hosted a scientific session at Hotel Padma, Semarang, focused on the evolving role of BP-SES — from clinical evidence to real-world practice.

We extend our sincere thanks to the esteemed presenters and discussants for sharing valuable clinical insights, and to all participants for their active engagement and thoughtful discussions.

Such platforms play a critical role in bridging research and practice, reinforcing our shared commitment to advancing interventional cardiology through evidence-based approaches and real-world experience.

Heart Valve Disease Awareness Day (Feb 22) reminds us to listen carefully.Heart valve disease is a global health challen...
22/02/2026

Heart Valve Disease Awareness Day (Feb 22) reminds us to listen carefully.

Heart valve disease is a global health challenge, affecting people across regions and age groups. Yet it remains under-recognized worldwide.

Awareness is the first step toward change.

# TAVI

From diagnosis to adulthood—progress in congenital heart care has transformed lives. With greater awareness and advances...
14/02/2026

From diagnosis to adulthood—progress in congenital heart care has transformed lives.

With greater awareness and advances in treatment, most children born with congenital heart defects today can grow up to live healthy, active lives.

This Congenital Heart Defect Awareness Week, let’s continue spreading knowledge that leads to early action and better outcomes.

Awareness saves hearts.

Congenital heart defects don’t have to define a child’s future.With early detection and appropriate medical care, many ...
12/02/2026

Congenital heart defects don’t have to define a child’s future. With early detection and appropriate medical care, many children can thrive and enjoy healthy, active lives.

Awareness saves hearts.

Congenital heart defects are not a single condition.They include a wide range of structural heart anomalies — from simp...
11/02/2026

Congenital heart defects are not a single condition. They include a wide range of structural heart anomalies — from simple septal defects to critical, complex malformations requiring early intervention.

Awareness saves hearts.

Advances in treatment mean that in high-resource settings, over 90% of children with congenital heart defects now surviv...
10/02/2026

Advances in treatment mean that in high-resource settings, over 90% of children with congenital heart defects now survive into adulthood.

This progress highlights what is possible with early diagnosis, access to care, and continued innovation.

Awareness saves hearts.

Most congenital heart defects are not inherited, only 20–30% are linked to genetic causes.Understanding the facts can re...
09/02/2026

Most congenital heart defects are not inherited, only 20–30% are linked to genetic causes.

Understanding the facts can reduce fear and encourage families to seek early care.

Awareness saves hearts.

Congenital heart defects represent nearly one third of all major birth defects worldwide.Raising awareness is the first ...
09/02/2026

Congenital heart defects represent nearly one third of all major birth defects worldwide.

Raising awareness is the first step toward better care.

Awareness saves hearts.

Every heart deserves a healthy start.Congenital heart defects affect 1 in 100 newborns globally, making them the most co...
07/02/2026

Every heart deserves a healthy start.

Congenital heart defects affect 1 in 100 newborns globally, making them the most common birth defect worldwide.

This , let’s raise awareness, support families, and advocate for early detection and care.

Awareness saves hearts.

Sahajanand Medical Technologies Ltd. (SMT) is pleased to announce that we have been honoured with the EY Pharma Award fo...
01/12/2025

Sahajanand Medical Technologies Ltd. (SMT) is pleased to announce that we have been honoured with the EY Pharma Award for Best Medical Device Company in the category of Export Promotion at the 12th edition of the India Pharma Awards, held on 25th November 2025 at the India Expo Centre, Greater Noida, Delhi NCR. his recognition stands as a testament to India’s strengthening presence on the global MedTech map and SMT’s commitment to shaping that journey. The award was received by Dr Rajiv Chhibber,VP External Affairs and his team on behalf of SMT.

Over the years, SMT has built a global footprint across Europe, APAC, Middle East and the Latin American region. This milestone reinforces the credibility of SMT as a global partner in advancing cardiovascular care.

The award is also an acknowledgment of our R&D, robust innovation ecosystem, and quality culture. As an Indian conglomerate rooted in advancing scientific technology, SMT has consistently focused on developing best-in-class medical technologies while ensuring an optimal experience for healthcare providers and patients alike. This recognition motivates us to continue pushing boundaries and delivering next-generation solutions to global markets.

At SMT, Excellence, Care, Innovation, and Agility are more than values, they are the foundation of our identity. This accolade reaffirms our commitment to being “Pledged to Save Millions”, a mission that inspires every member of the SMT family. We extend our gratitude to the Jury, E&Y team, our global partners, clinicians, customers, and teams whose constant support has made this achievement possible. The journey ahead is promising, and together, we will continue elevating patient care across the world.

We are pleased to invite the interventional cardiology community to two focused scientific sessions by SMT at GIS 2025, ...
26/11/2025

We are pleased to invite the interventional cardiology community to two focused scientific sessions by SMT at GIS 2025, where leading clinicians will share evidence and real-world insights in PCI and TAVR.

Session 1A

Topic: Improving Outcomes in PCI: The Clinical Evidence Behind Supraflex Cruz

Speaker: Dr. Samih Lawand, MD, FRCPC, FACC

Affiliation: Consultant Interventional Cardiologist; Head of Cardiology, Dallah Hospital, Riyadh KSA

Date: 28 November 2025

Time: 14:30 – 14:45

Venue: Hall B, Intercontinental Dubai Festival City

Session 1B

Topic: Hydra Valve: Case-Based Learning & Updated Evidence

Speaker: Dr. Waleed Al Harbi

Affiliation: Interventional Cardiology Consultant, King Khaled University Hospital

Date: 28 November 2025

Time: 14:45 – 15:00

Venue: Hall B, Intercontinental Dubai Festival City

SMT continues to support evidence-based innovation and meaningful scientific exchange.We look forward to meeting the global community at GIS 2025.

Sahajanand Medical Technologies is pleased to announce its participation in the GIS Annual Conference, taking place in D...
25/11/2025

Sahajanand Medical Technologies is pleased to announce its participation in the GIS Annual Conference, taking place in Dubai, UAE from 27–29 November 2025.

We invite all attendees to visit our booth to explore our latest product innovations and newly generated clinical evidence. We look forward to engaging with you at GIS 2025.

Address

Sahajanand Estate, Wakhariawadi, Nr. Dabholi Char Rasta, Ved Road
Surat
395004

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm
Saturday 8:30am - 5pm

Telephone

+912616112800

Alerts

Be the first to know and let us send you an email when Sahajanand Medical Technologies Ltd. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Sahajanand Medical Technologies Ltd.:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram